Day 1 - SGT / Singapore
Medtech in the Asia Pacific is at a pivotal moment, with growing demand for advanced healthcare solutions and increasing investment in innovation. This panel will delve into the unique opportunities and challenges facing Medtech companies in the region and outline actionable steps for sustainable growth.
- Emerging trends and opportunities in the Asia Pacific Medtech landscape
Navigating regulatory hurdles and market-specific challenges
Building a roadmap for innovation, collaboration, and commercialization
Family offices are increasingly investing in medtech and digital health startups, offering patient capital and strategic support. This panel will provide insights into how startups can attract family office investment and build lasting relationships with these unique investors.
Understanding the investment priorities of family offices
Crafting compelling pitches tailored to family office investors
Building trust and long-term relationships with family offices
Regulatory harmonization is critical for medtech companies seeking to scale across the Asia Pacific region. This panel will examine the feasibility, timelines, and progress of regulatory alignment, and its impact on innovation and market access.
Current state of medtech regulations in the Asia Pacific
Challenges and opportunities in regulatory harmonization
Practical steps for navigating regulatory frameworks across the region